Cargando…

P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE

Detalles Bibliográficos
Autores principales: Agustina Perusini, Maria, Gupta, Vikas, Bankar, Aniket, Sibai, Jad, Minden, Mark, Maze, Dawn, Davidson, Marta, Richard-Carpentier, Guillaume, M Chan, Steven, Schuh, Andre, Yee, Karen, Atenafu, Eshetu, Sibai, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428392/
http://dx.doi.org/10.1097/01.HS9.0000968448.07133.3e
_version_ 1785090458091782144
author Agustina Perusini, Maria
Gupta, Vikas
Bankar, Aniket
Sibai, Jad
Minden, Mark
Maze, Dawn
Davidson, Marta
Richard-Carpentier, Guillaume
M Chan, Steven
Schuh, Andre
Yee, Karen
Atenafu, Eshetu
Sibai, Hassan
author_facet Agustina Perusini, Maria
Gupta, Vikas
Bankar, Aniket
Sibai, Jad
Minden, Mark
Maze, Dawn
Davidson, Marta
Richard-Carpentier, Guillaume
M Chan, Steven
Schuh, Andre
Yee, Karen
Atenafu, Eshetu
Sibai, Hassan
author_sort Agustina Perusini, Maria
collection PubMed
description
format Online
Article
Text
id pubmed-10428392
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104283922023-08-17 P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE Agustina Perusini, Maria Gupta, Vikas Bankar, Aniket Sibai, Jad Minden, Mark Maze, Dawn Davidson, Marta Richard-Carpentier, Guillaume M Chan, Steven Schuh, Andre Yee, Karen Atenafu, Eshetu Sibai, Hassan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428392/ http://dx.doi.org/10.1097/01.HS9.0000968448.07133.3e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Agustina Perusini, Maria
Gupta, Vikas
Bankar, Aniket
Sibai, Jad
Minden, Mark
Maze, Dawn
Davidson, Marta
Richard-Carpentier, Guillaume
M Chan, Steven
Schuh, Andre
Yee, Karen
Atenafu, Eshetu
Sibai, Hassan
P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
title P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
title_full P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
title_fullStr P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
title_full_unstemmed P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
title_short P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
title_sort p385: comparison of clinical outcomes and adverse events in older adults with acute lymphoblastic leukemia treated with native vs pegylated asparaginase
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428392/
http://dx.doi.org/10.1097/01.HS9.0000968448.07133.3e
work_keys_str_mv AT agustinaperusinimaria p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT guptavikas p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT bankaraniket p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT sibaijad p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT mindenmark p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT mazedawn p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT davidsonmarta p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT richardcarpentierguillaume p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT mchansteven p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT schuhandre p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT yeekaren p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT atenafueshetu p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase
AT sibaihassan p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase